Carol M Moinpour

Summary

Affiliation: Fred Hutchinson Cancer Research Center
Country: USA

Publications

  1. ncbi Health-related quality-of-life findings for the prostate cancer prevention trial
    Carol M Moinpour
    Public Health Sciences Division, Fred Hutchinson Cancer Research Center, M3 C102 1100 Fairview Ave North, PO Box 19024 Seattle, WA 98109 1024, USA
    J Natl Cancer Inst 104:1373-85. 2012
  2. ncbi Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel monothe
    Carol M Moinpour
    Fred Hutchinson Cancer Research Center M3 C102, 1100 Fairview Avenue North, P O Box 19024, Seattle, WA 98109 1024, USA
    Qual Life Res 21:765-75. 2012
  3. ncbi Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial
    Carol M Moinpour
    Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center M3 C102, 1100 Fairview Ave North, Box 19024, Seattle, WA 98109 1024, USA
    J Natl Cancer Inst 99:1025-35. 2007
  4. ncbi Funding patient-reported outcomes in cancer clinical trials
    Carol M Moinpour
    Southwest Oncology Group Statistical Center Fred Hutchinson Cancer Research Center, Seattle, WA 98104 1024, USA
    J Clin Oncol 25:5100-5. 2007
  5. ncbi Chemotherapeutic impact on pain and global health-related quality of life in hormone-refractory prostate cancer: Dynamically Modified Outcomes (DYNAMO) analysis of a randomized controlled trial
    Carol M Moinpour
    Southwest Oncology Group Statistical Center, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Qual Life Res 18:147-55. 2009
  6. ncbi Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancer
    Carol M Moinpour
    Southwest Oncology Group Statistical Center, Seattle, WA 98105, USA
    J Clin Oncol 28:3611-6. 2010
  7. ncbi Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, 1100 Fairview Ave North, M3 B232, Seattle, WA 98109 1024, USA
    World J Urol 29:3-9. 2011
  8. ncbi Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer
    Steven B Zeliadt
    Department of Veterans Affairs Medical Center, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    BJU Int 108:851-6; discussion 856-7. 2011
  9. ncbi Quality of life and pain in advanced stage prostate cancer: results of a Southwest Oncology Group randomized trial comparing docetaxel and estramustine to mitoxantrone and prednisone
    Donna L Berry
    University of Washington, Seattle, WA 98195 7266, USA
    J Clin Oncol 24:2828-35. 2006
  10. ncbi Patient income level and cancer clinical trial participation
    Joseph M Unger
    SWOG Statistical Center, Fred Hutchinson Cancer Research Center, M3 C102, 1100 Fairview Ave, Seattle, WA 98109, USA
    J Clin Oncol 31:536-42. 2013

Detail Information

Publications27

  1. ncbi Health-related quality-of-life findings for the prostate cancer prevention trial
    Carol M Moinpour
    Public Health Sciences Division, Fred Hutchinson Cancer Research Center, M3 C102 1100 Fairview Ave North, PO Box 19024 Seattle, WA 98109 1024, USA
    J Natl Cancer Inst 104:1373-85. 2012
    ....
  2. ncbi Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel monothe
    Carol M Moinpour
    Fred Hutchinson Cancer Research Center M3 C102, 1100 Fairview Avenue North, P O Box 19024, Seattle, WA 98109 1024, USA
    Qual Life Res 21:765-75. 2012
    ..This manuscript presents health-related quality of life (HRQL) results from a phase III trial of gemcitabine-paclitaxel (GT) versus paclitaxel (T) in metastatic breast cancer patients...
  3. ncbi Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial
    Carol M Moinpour
    Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center M3 C102, 1100 Fairview Ave North, Box 19024, Seattle, WA 98109 1024, USA
    J Natl Cancer Inst 99:1025-35. 2007
    ..The PCPT offered an opportunity to prospectively study the effects of finasteride and other covariates on sexual dysfunction...
  4. ncbi Funding patient-reported outcomes in cancer clinical trials
    Carol M Moinpour
    Southwest Oncology Group Statistical Center Fred Hutchinson Cancer Research Center, Seattle, WA 98104 1024, USA
    J Clin Oncol 25:5100-5. 2007
    ....
  5. ncbi Chemotherapeutic impact on pain and global health-related quality of life in hormone-refractory prostate cancer: Dynamically Modified Outcomes (DYNAMO) analysis of a randomized controlled trial
    Carol M Moinpour
    Southwest Oncology Group Statistical Center, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Qual Life Res 18:147-55. 2009
    ..This paper applies the Dynamically Modified Outcomes (DYNAMO) model to a clinical trial of two chemotherapeutic regimens on global health-related quality of life (GHRQL) in hormone-refractory prostate cancer...
  6. ncbi Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancer
    Carol M Moinpour
    Southwest Oncology Group Statistical Center, Seattle, WA 98105, USA
    J Clin Oncol 28:3611-6. 2010
    ..S0205 was a randomized clinical trial that compared the therapeutic impact of gemcitabine versus gemcitabine plus cetuximab. Study results for patient-reported health-related quality of life (HRQL) outcomes are reported...
  7. ncbi Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, 1100 Fairview Ave North, M3 B232, Seattle, WA 98109 1024, USA
    World J Urol 29:3-9. 2011
    ..We hypothesized that urologists present a wider range of management recommendations and are less likely to consider the patient preference during the initial consultation...
  8. ncbi Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer
    Steven B Zeliadt
    Department of Veterans Affairs Medical Center, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    BJU Int 108:851-6; discussion 856-7. 2011
    ..To evaluate the degree to which the partners of prostate cancer patients participate in the shared decision-making process with the patients' providers during the time between diagnosis and initiating treatment...
  9. ncbi Quality of life and pain in advanced stage prostate cancer: results of a Southwest Oncology Group randomized trial comparing docetaxel and estramustine to mitoxantrone and prednisone
    Donna L Berry
    University of Washington, Seattle, WA 98195 7266, USA
    J Clin Oncol 24:2828-35. 2006
    ..While Southwest Oncology Group trial 99-16 demonstrated a survival improvement of DE over MP, the study also was designed to compare the palliation of disease-related symptoms...
  10. ncbi Patient income level and cancer clinical trial participation
    Joseph M Unger
    SWOG Statistical Center, Fred Hutchinson Cancer Research Center, M3 C102, 1100 Fairview Ave, Seattle, WA 98109, USA
    J Clin Oncol 31:536-42. 2013
    ..Studies have shown an association between socioeconomic status (SES) and quality of oncology care, but less is known about the impact of patient SES on clinical trial participation...
  11. ncbi A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316)
    Sara H Javid
    Department of Surgery, Division of Surgical Oncology, University of Washington Medical Center, 1959 NE Pacific St, Seattle, WA 98195 6410, USA
    Oncologist 17:1180-90. 2012
    ..Patients older than 65 years are underrepresented in clinical trials. We conducted a prospective study (SWOG S0316) to determine physician- and patient-perceived barriers to breast cancer clinical trial enrollment for older patients...
  12. ncbi Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy
    Carol M Moinpour
    Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    J Clin Oncol 26:112-20. 2008
    ..To compare short- and long-term effects of adjuvant treatment versus observation after surgery on health-related quality of life (HRQL) of prostate cancer patients...
  13. ncbi Preliminary treatment considerations among men with newly diagnosed prostate cancer
    Steven B Zeliadt
    Health Services Research and Development Center of Excellence, VA Puget Sound Health Care System, Seattle, WA, USA
    Am J Manag Care 16:e121-30. 2010
    ..To assess factors that may influence men's preference for surgery versus nonsurgical options among newly diagnosed patients considering treatments for local-stage prostate cancer...
  14. ncbi Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small-cell lung cancer
    Scott D Ramsey
    Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    J Natl Cancer Inst 94:291-7. 2002
    ..There were no statistically significant differences in survival or cancer-related quality of life between the treatment arms...
  15. ncbi Recruiting patients with breast cancer and their families to behavioral research in the post-HIPAA period
    Deborah J Bowen
    Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Oncol Nurs Forum 34:1049-54. 2007
    ....
  16. ncbi Assessing meaningful change in quality of life over time: a users' guide for clinicians
    Mirjam A G Sprangers
    Department of Medical Psychology, Academic Medical Center, University of Amsterdam, The Netherlands
    Mayo Clin Proc 77:561-71. 2002
    ....
  17. ncbi Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
    Scott M Lippman
    The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    J Natl Cancer Inst 97:94-102. 2005
    ....
  18. ncbi Learning to live with missing quality-of-life data in advanced-stage disease trials
    Gary W Donaldson
    J Clin Oncol 23:7380-4. 2005
  19. ncbi Sequential vinorelbine and docetaxel in advanced non-small cell lung cancer patients age 70 and older and/or with a performance status of 2: a phase II trial of the Southwest Oncology Group (S0027)
    Paul J Hesketh
    Caritas St. Elizabeth's Medical Center of Boston, Boston, MA, USA
    J Thorac Oncol 1:537-44. 2006
    ..CONCLUSION: Sequential vinorelbine and docetaxel is a well-tolerated and effective regimen in comparison with reports of other treatments tested in patients with advanced NSCLC age 70 and older and/or with a PS of 2...
  20. ncbi Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626
    J Wendall Goodwin
    Cancer Research for the Ozarks, 1730 E Republic Rd, Suite V, Springfield, MO 65804, USA
    J Clin Oncol 26:1650-6. 2008
    ..Prior progestin studies treating hot flashes in women have been short duration and single dose. This study tests the progestin megestrol acetate (MA) at two doses versus placebo over 6 months...
  21. ncbi Data pooling and analysis to build a preliminary item bank: an example using bowel function in prostate cancer
    David T Eton
    Northwestern University School of Medicine, Evanston, IL 60201, USA
    Eval Health Prof 28:142-59. 2005
    ..A fifth item assessing hemorrhoids was poorly correlated with other items. Our analyses supported four related components of BF: diarrhea, rectal urgency, pain, and bother/distress...
  22. ncbi Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897
    Patricia A Ganz
    School of Medicine, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, 650 Charles Young Dr South, Room A2 125 CHS, Los Angeles, CA 90095 6900, USA
    J Clin Oncol 26:1223-30. 2008
    ..The late cardiac effects of adjuvant anthracycline therapy in survivors of early-stage breast cancer have had limited study. Subclinical and clinical cardiac late effects may contribute to added comorbidity over time...
  23. ncbi Phase II trial of vinorelbine for relapsed ovarian cancer: a Southwest Oncology Group study
    Mace L Rothenberg
    Vanderbilt Ingram Cancer Center, 777 Preston Research Building, Nashville, TN 37232 6307, USA
    Gynecol Oncol 95:506-12. 2004
    ....
  24. ncbi Social networks and quality of life among female long-term colorectal cancer survivors
    Amy L Sapp
    University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin 53726, USA
    Cancer 98:1749-58. 2003
    ..The results of this study should be of interest to those seeking to understand or improve HRQoL among this growing population...
  25. ncbi Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133
    Patricia A Ganz
    University of California, Los Angeles, Los Angeles, CA, USA
    J Clin Oncol 21:3512-9. 2003
    ..The mechanisms responsible for this lingering problem warrant further investigation...
  26. ncbi Individual differences in quality-of-life treatment response
    Gary W Donaldson
    Department of Anesthesiology, Pain Research Center, School of Medicine, University of Utah, Salt Lake City 84108, USA
    Med Care 40:III39-53. 2002
    ....
  27. ncbi Erectile dysfunction and subsequent cardiovascular disease
    Ian M Thompson
    Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
    JAMA 294:2996-3002. 2005
    ..The risk factors for cardiovascular disease and erectile dysfunction are similar...